that c-myc expression is an absolute requirement for cellular to exert an antiproliferative effect in myeloid cells. How the antitransformation by p210 BCR-ABL. 4 Further, a nontransforming proliferative activity of cAMP is exerted in p210 BCR-ABL transmutant form of pBCR-ABL incorporating a mutation in the ABL gression from G1 to S, of raising the intracellular concen-
tration of cyclic AMP (cAMP) within hematopoietic cells transformed by p210 BCR-ABL. Indeed, cAMP is an important hematopoietic intracellular second messenger that particiIntroduction pates in hematopoietic developmental decisions to differentiate, arrest, or undergo apoptosis. 12, 13 It was hypothesized The mechanism for hematopoietic transformation by p210 that cAMP would alter a dynamic equilibrium between free BCR-ABL, product of the Philadelphia chromosome of chronic and Rb-bound E2F1 at the c-myc promoter cis element by granulocytic leukemia, has been subjected to intensive scruaffecting the activity of cdk4 and the abundance of its regulattiny. Studies have identified two signaling pathways initiated ory D-type cyclin. 7 by p210 BCR-ABL, both of which are necessary for transformWe found that raising intracellular cAMP within p210 BCRation. One pathway involves p21RAS, whose downstream ABL transformed cells resulted in two individually distinctive nuclear end-point is on c-jun/AP-1 expression. 1 Intermediates blocks in G1 phase of the cell cycle, and the mechanism of in this pathway appear to be the extracellular-regulated kinase one of these blocks (cAMP-induced delay at an early G1 (ERK) and the c-jun N-terminal kinase, JNK. 2 point) was further elucidated. The early G1 phase delay affec-A second pathway from p210 BCR-ABL ends on c-myc tranted by cAMP involved diminished cdk4 activity on the retinoscription, and this pathway appears to be at least partly disblastoma protein, pRb. Diminished cdk4 activity imposed by tinct from the pathway to c-jun and c-fos. 3, 4 It was shown cAMP in these cells traversing the early G1 phase was directly linked to reduced concentration of the cdk4-regulatory, cyclin D1 protein. Ultimately, loss of cdk4 activity resulted in (1) increased formation of Rb:E2F1 complexes in a matrix-asso- tional activity of c-myc under the control of a minimal P2
promoter containing the E2F element. Therefore, cyclin D1 according to the manufacturer's protocol. Poly A + RNA was prepared by oligo dT cellulose chromatography (Boehringer co-operates with c-myc in p210 BCR-ABL transformed cells, at least in part, in direct series in the same pathway, and not Mannheim, Indianapolis, IN, USA) in spin columns (BioRad, Hercules, CA, USA). exclusively in a parallel pathway. It was found that cyclin D1 participates in a pathway from cdk4 to generate active E2F1, Poly A + RNA was electrophoresed in a 1% agarose-formaldehyde gel in Na 2 PO 4 buffer containing 4% formaldehyde. a critical transcriptional regulator of c-myc, required for p210 BCR-ABL transformation.
Following this, the RNA was transferred to nitrocellulose. Hybridizations proceeded at 42°C in 50% formamide, and the blots were washed at 37°C in 2 × SSC (standard saline citrate)/0.1% SDS and 1 × SSC/0.1% SDS for a total of four Materials and methods times 15 min.
Cells and cell culture H7 Bcr-Abl.A54, a p210 BCR-ABL transformed factor-inde-DNA probes and vectors pendent cell line derived from parental IL-3-dependent murine myeloid cell line NSF/N1.H7, has been previously described. 1 The p210 BCR-ABL transformed cells were mainThe following probes were used for the Northern blot hybridizations: c-myc exon 2,3: 5. Cell synchronization was used as probe. 17 The CHO-B probe served as a control for RNA loading on Northern blots because it is constitutively The rationale for centrifugal elutriation in analysis of cell cycle events has been described by others.
14 This was performed expressed in murine cells. 17 These probes were labeled with a 32 P-dCTP by a random priming kit (Boehringer Mannheim). on a Beckman (Fullerton, CA, USA) J2-21M induction drive centrifuge with rotor JE-6B. For cellular fractionation into synchronized populations, cells were removed from log-phase growth and were resuspended into an elutriation medium Immunoprecipitation and immunoblotting consisting of ice-cold phosphate-buffered saline (PBS) containing 5% heat-inactivated bovine calf serum, 0.01% EDTA, and 0.02% D-glucose. Cells were loaded onto the rotor spinNuclear or cytosolic proteins were isolated as previously described. 1, 11 For immunoprecipitation, 200 g of cytosolic or ning at 1950 r.p.m. at an initial pump flow rate of 8 ml/min at 10°C. Fractions were collected from incremental increases nuclear protein extracts were incubated with 15 l protein G PLUS agarose (Oncogene Science) and 1 g of specific antiin the flow rate up to 26 ml/min (open rotor) and were analyzed for DNA content by propidium iodide (PI) staining and body with gentle rocking at 4°C for 18 h. The agarose beads were washed carefully twice, and finally resuspended in 40 l flow cytometric analysis on a Becton Dickinson (Mountain View, CA, USA) FACScan machine with a Cellfit analysis pro-SDS loading buffer (10% glycerol, 5% 2-mercaptoethanol, 2.3% SDS, 75 mm Tris.Cl pH 6.8, 0.05% bromophenol blue) gram supplemented by a Modfit statistical analysis package. After initial calibration, fractions of approximately 100 ml and boiled for 10 min prior to SDS-PAGE electrophoresis. Nuclear proteins (25 g) or immunoprecipitates (20 l) were routinely collected and pooled to give three separate populations. Pooled fractions 8-16 were highly enriched for were resolved on 12% or 6% mini SDS-polyacrylamide gels (BioRad) and then transferred to a nitrocellulose filter by a cells with G1 content of DNA (2N) (72.8 ± 4.8% G1; 23.3 ± 5.6% S), and fractions Ͼ26 were highly enriched for semi-dry Western blotting method. The filter was preblocked in 5% non-fat dried milk in TBS-T (Tris buffered saline, 0.5% cells with S-phase DNA content (76.1 ± 9.5% S); 10.5 ± 8.0% G1). The pooled cells collected from fractions Tween 20) at 4°C for 24-48 h. The Western blots were washed at room temperature in TBS-T and then incubated 17-26 represented a unique population not only in cell size/density and DNA content, but also in functional capawith primary antibody diluted 1:1000 in TBS-T for 1-4 h at room temperature. Detection of the primary antibody was bility. This cell fraction (17-26 pooled) had an intermediate content of DNA and had two-fold greater incorporation of 3 Hdone using a secondary antibody conjugated to horseradish peroxidase at 1:3000 dilution in TBS-T, developed by a chemthymidine into DNA in a 6 h period following reintroduction into cell culture compared to the G1 (fractions 8-16) or Siluminescent reaction (Amersham) and exposed to radiographic film. The Western blots were stripped and reprobed phase enriched (Ͼ26) fractions. Thus, the G1 and S-enriched fractions were enriched in cells that were at least 6 h from with other relevant antibodies. onset of new DNA synthesis, whereas the 17-26 fraction was at G1/S interface.
Antibodies Isolation of RNA and Northern blot analysis
The following antibodies were used for this study: anti-Rb G3-245 (PharMingen, San Diego, CA, USA); anti-E2F1, anti-cdk2, Aliquots of cells from the pooled elutriated fractions were placed into culture in duplicates, either untreated or treated anti-cdk4, anti-cyclin D1, anti-cyclin D (UBI, Lake Placid, NY, USA); anti-cyclin E (Santa Cruz Biol, Santa Cruz, CA, USA); with one of the following: 8BrcAMP (1 mm) or forskolin (100 m). 8BrcAMP is a cell permeable cAMP analogue anti-actin Ab1 (Oncogene Science, Uniondale, NY, USA); horseradish peroxidase conjugated anti-mouse and anti-rabbit (Sigma, St Louis, MO, USA). Cells were incubated for 2-18 h, after which time total RNA was extracted using Trizol (Gibco) (Amersham, Arlington Heights, IL, USA).
Transient transfections so as to allow entry into DNA synthetic (S) phase. 15, 22, 23 Both c-myc transcriptional expression and the activity of cdk4, a The P2 c-myc promoter was subcloned into the promoterless putative regulatory kinase controlling c-myc gene's transactivpXP2 luciferase vector as described previously. 11 The wildation, are highly cell cycle-regulated events. In order to study type P2 promoter luciferase vector consisted of the PvuII-XhoI regulation of cdk4, and its possible antecedent influence over (−134 to +359) fragment cloned into the correct orientation of c-myc mRNA expression, we isolated cell cycle synchronized the multicloning site of the luceriferase vector pXP2. A derivapopulations of p210 BCR-ABL transformed cells for study of tive 5Ј c-myc P2 luciferase vector containing site-directed the effect of raised intracellular cAMP. It was postulated that mutation of the E2F motif (TTGGCGGGAAA to the cell cycle window might be restricted for successful TTGGATCCAAA) was prepared by the technique of combinaexecution by cAMP of an anti-proliferative signal targeted at torial PCR-mediated mutagenesis as previously described, 18 regulation of c-myc and cdk4. and was named mut E2FP2-luciferase (clone 9C). The mutant First, the overall effects of raised cAMP on cell cycle pro-E2F site was tested for ability to bind E2F in cell extracts and gression in the synchronized populations was studied. Bcrwas lacking in this capacity. 11 The veracity of the incorporated Abl.A54 cells were isolated by centrifugal elutriation into alimutant sequence was confirmed by sequencing. Cells were quots highly enriched for G1 content of DNA. This population transfected by electroporation by methodology described preconsisted of pooled elutriator fractions [8] [9] [10] [11] [12] [13] [14] [15] [16] . FACS analysis of viously. 19 In brief, the cells were resuspended in Ca 2+ /Mg 2+ -PI-stained cells in this pooled population in five consecutive free PBS containing 20 mm Hepes. Vector DNA was added at experiments revealed that 72.8 ± 4.8% of this pooled popu-2 g/10 6 cells for the luciferase vectors, and 1 g/10 6 cells for lation was G1, whereas 23.3 ± 5.6% of cells were in S phase. RSV ␤-galactosidase to serve as an internal control for transNext, fractions highly S-phase enriched were obtained. Pooled fection efficiency. The cell/DNA mixture was incubated on fractions Ͼ26 consisted of 76.1 ± 9.5% S phase cells and ice for 10 min, and then exposed to a pulse of 320-350 V at 10.5 ± 8.6% G1-phase cells (five experiments). These fractions 500 F, delivered over 10-13 mins (BioRad gene pulser with were then incubated overnight in culture in the presence or capacitance extender). After a second 10 min incubation on absence of 8BrcAMP to observe for antiproliferative effect of ice, the cells were resuspended at 1 × 10 6 /ml in McCoy's supraised intracellular cAMP. plemented with 10% FCS in the presence or absence of forBoth groups of cells (G1-enriched/fractions 8-16, and Sskolin (100 m) overnight (15-18 h). The cells were isolated enriched/fractions Ͼ26) were inhibited from unrestricted cell and cytosolic extracts were prepared for luciferase activity cycle movement by addition of 8BrcAMP (1 mm) to the media, analysis by methods recommended by the manufacturer of the when compared to their untreated control aliquots ( Figure 1 ). luciferase assay kit (Promega, Madison, WI, USA). Data were
In a set of representative experiments, a G1 fraction (81% reported as luciferase activity/␤-galactosidase for equal alipure) was prevented from S phase entry (43% S entry in conquots of cells subjected to cytosol extraction.
trol vs 0% in 8BrcAMP-treated aliquots) (Figure 1a , top). In a series of 10 experiments, 8BrcAMP reduced by 66% the fraction of cells capable of entering S phase from G1 (mean %S cdk4 kinase activity assay (+cAMP)/%S (untreated) + %S (+cAMP)). Conversely, in those cells purified for S phase and then subCellular proteins, 200 g, were immunoprecipitated overnight jected to overnight incubation in culture medium in the preswith gentle rocking at 4°C, with 5 g of anti-cdk4 (UBI) and ence or absence of 8BrcAMP, cells were blocked in the next protein G PLUS agarose (Oncogene Science) in a final volume G1 phase by 8BrcAMP ( Figure 1b ; starting population, 81% of 500 l in lysis buffer (20 mm Tris HCl, pH 8.0, 137 mm S; after control incubation = 52.8% G1/40.5% S vs 8BrcAMP NaCl, 10% glycerol, 1 mm PMSF, 0.15 U/ml aprotonin, incubation = 63.2% G1/18.8%S) (Figure 1b , top). In neither of 10 mm EDTA, 10 g/ml leupeptin, 10 mm NaF, 2 mm orthothe starting fractions obtained by centrifugal elutriation (G1 or vanadate, 1% NP-40). 20 The beads were washed twice in lysis S) did incubation with 8BrcAMP augment the fraction of cells buffer, and twice in cold 50 mm Hepes, pH 7.5, 1 mm DTT.
arrested in G2/M after overnight incubation (mean of 10 The beads were then resuspended in 30 l kinase buffer experiments): fractions 8-16: 5.2 vs 5.5%, 8BrcAMP vs con-(50 mm Hepes, pH 7.5, 10 mm MgCl 2 , 1 mm DTT, 2.5 mm trol, respectively; Ͼ26: 9.4 vs 9.7%, BrcAMP vs control. EGTA, 0.1 mm Na vanadate, 1 mm NaF, 20 m ATP) containing 2 g GST-Rb (amino acids 384-928, Ase-End, a gift of Dr Jean Wang, University of California, San Diego). 20, 21 This was cAMP-mediated delay of G1 population growth in followed by the addition of 1 Ci gamma-32 P-ATP, and the culture accompanies c-myc mRNA inhibition reaction was incubated at 30°C for 30 min, then stopped by the addition of an equal volume of 2 × SDS-PAGE sample We reasoned that since c-myc is an early response gene buffer. The reaction contents were boiled and then electrophnecessary for active progression of the G1 cell cycle phase, oresed on 10% SDS-PAGE gels, which were dried and subtreatments that effect early G1 phase delay would also markjected to autoradiography. Mock immunoprecipitation control edly reduce c-myc mRNA accumulation. We focused on the groups failed to reveal kinase activity for GST-Rb.
S-phase enriched elutriated population as a likely candidate population in which to study in chronologic detail the mode of c-myc accumulation during the course of incubation in culResults ture of cells synchronously transiting early G1. A time-course for cell cycle evolution of this population in cAMP acts on different synchronized p210 BCR-ABL culture was performed ( Figure 2 ). In a representative experitransformed myeloid cell populations to retard cycle ment, the elutriated S-phase population (fractions Ͼ26) was progression 61% pure (with 31% G1 contamination) and was subjected to a time-course cell cycle analysis in culture in the presence C-myc transcriptional expression has been closely tied to cells' ability to accomplish cell cycle progression in G1 phase, or absence of 8BrcAMP ( Figure 2) . Growth of the G1 popu- .5% S (top) or 81.6% G1/18.4% S (bottom). Replicate aliquots were subjected to control incubation or to incubation with 8BrcAMP (1 mm) and were analyzed after overnight incubation: (Top) control (middle) 56.4% G1/43.1% S vs 8BrcAMP (right) 100% G1/0% S. (Bottom) control (middle) 54.0% G1/41.4% S vs 8BrcAMP (right), 72.7% G1/17.8% S. (b) Two experiments are shown (top and bottom) in which cells were isolated from elutriated fractions Ͼ26 for S-phase content of DNA: 63.4% S/18.2% G1 (top) or 88.8% S/11.2% G1 (bottom). Replicate aliquots were subjected to control incubation or to incubation with 8BrcAMP (1 mm) and were analyzed after overnight incubation: (Top) control (middle); 54.3% G1/38.6% S vs 8BrcAMP (right) 72.8% G1/25.7% S. (Bottom) control; 52.8% G1/40.5% S vs 8BrcAMP (right); 65.2% G1/18.5% S.
lation was monitored at intervals of 30 min up to 2 h, and by 10 h (Figure 2, top) . Upon overnight culture, the control (Ͼ26, untreated) population had first entered G1 and then synchronless frequent sampling overnight. Growth of the G1 fraction assessed by propidium iodide staining was observed at 6 h ously departed G1 for the next S phase, but 8BrcAMP treatment caused a build-up of cAMP-treated cell aliquot in G1 post-incubation in culture in the control aliquot. 8BrcAMP markedly delayed growth of the G1 population between 6 and ( Figure 2 ).
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was modest in this G1 fraction or in the G1/S fraction during the 6 h 8BrcAMP treatment: Ͻ50% reduction ( Figure 3 ). By contrast, in the pooled fractions Ͼ26 progressing from S into early G1 upon 6 h incubation, c-myc mRNA accumulation was less advanced in its cell cycle dependent evolution, and the impact of 8BrcAMP treatment was marked, resulting in 98% reduction of c-myc transcripts upon 8BrcAMP treatment ( Figure 3) . Other experiments were performed that demonstrated cAMP treatment did not affect c-myc mRNA stability (transcript half-life unchanged at 15 min after actinomycin D treatment with or without 8BrcAMP) (data not shown). Also, identical inhibition of c-myc mRNA was observed after treatment of cells with the adenyl cyclase activator, forskokin (data not shown).
These data suggested a distinctive early G1 checkpoint in which c-myc accumulation by a transcriptional mechanism was particularly sensitive to raised intracellular cAMP. We pursued further the mechanism for this phenomenon.
Transcriptional repression of c-myc by increased intracellular cAMP
Previous experiments established the critical role of the c-myc P2 promoter for transcription initiation of c-myc in these BCR-ABL transformed cells. 11 The potential for cAMP-mediated regulation of the P2 c-myc promoter was directly addressed in reporter assays with the P2 c-myc promoter in control of firefly luciferase (Figure 4 ). The individual fractions were transfected with the 5Ј c-myc P2 reporter construct and a control ␤-galactosidase vector, and half of each group was treated with forskolin ( Figure 4) . (8BrcAMP could not be used in reporter experiments due to autofluorescent properties.)
Interestingly, P2 c-myc-mediated reporter activity was greatest in the Ͼ26 elutriated cell fraction progressing through G1 phase in culture after the purification and transfection steps, as compared to the 8-16 elutriated fraction, also recultured after transfection (Figure 4 ). This result seen in reporter assays with cells in early G1 (S-to-G1 population), was possibly indicative of an antecedent role for interactions between transcription factors and the P2 promoter in leading to greatest c-myc mRNA transcript accumulation later in G1, assayed by Northern blot analysis (Figures 3 and 4) .
Most importantly, the degree of forskolin-mediated suppression of the P2 c-myc promoter was marked in the incu-
Figure 2
Time course for cell cycle evolution in culture from the S-phase fraction and the effect of 8BrcAMP. The S-phase enriched bated Ͼ26 fraction, as compared with the amount of inhifraction was obtained by centrifugal elutriation and an aliquot was bition in the G1-enriched population subjected to incubation analyzed by PI staining: 61% S/31% G1. Replicate aliquots were after transfection (72 Ϯ 6% inhibition for S-to-G1 vs 46 control in these cells. 11 Therefore, a series of gel mobility shift was observed at 6 and 10 h, but the effect of 8BrcAMP on G2/M or experiments was undertaken to confirm a regulatory role for S phase fractions was largely restricted to the 6 h or 10 h time points, raised intracellular cAMP on binding of E2F to the consensus respectively.
sites of the P2 c-myc probe or to a model E2F consensus of the E2A adenovirus promoter (data not shown). In these experiments we found that 8BrcAMP treatment of S-phase Expression of c-myc mRNA was examined in these same cell fractions subjected to incubation in culture for the critical enriched cells, incubated in culture for the opportunity to transit G1, reduced the relative content of free, deoxycholate-6 h time period, either in the presence or absence of 8BrcAMP (Figure 3 ). This included the G1 (8-16) or S (Ͼ26) cell fracresistant E2F complexes formed by binding of cell extracts to radiolabeled E2F probes from the c-myc or E2A promoters; tions, or the intervening elutriator fractions (17-26 pooled) characterized by intermediate cell size and DNA content 8BrcAMP treatment also prevented the formation of a slowly migrating protein-associated complex of E2F1 that involved (G1/S). Expression of c-myc mRNA was greatest in the G1 fraction (Figure 3) . 8BrcAMP-mediated inhibition of c-myc cdk2, which is known to be specific for the S-phase of the cell
Figure 3
Raised intracellular cAMP causes greatest inhibition of c-myc mRNA expression in cells synchronously progressing into early G1 phase from the end of S phase; cyclin D1 mRNA expression is relatively insensitive to inhibition by raised cAMP except in this cell group entering early G1. Overall c-myc transcript expression is greatest in G1 phase (1.4-fold greater than G1/S fraction). Comparisons were made by densitometric analysis of autoradiograms and ratios were corrected for expression of the housekeeping gene, CHO-B. In the fraction of cells enriched for completion of S phase upon centrifugal elutriation, and then subjected to incubation in the absence or presence of 8BrcAMP,cmyc mRNA expression was inhibited by 98% by cAMP, and cyclin D1 mRNA transcripts were inhibited 86% by raised intracellular cAMP. In the cell aliquot enriched for G1 phase cells and allowed to incubate in culture, and in the intermediate-sized elutriated fraction closest to DNA synthesis (G1/S), c-myc mRNA was inhibited by approximately 50%, but cyclin D1 mRNA was only diminished by 10-20%, respectively. cycle (data not shown, see also Ref. 24). In addition, nuclear cAMP inhibits cdk4 phosphorylation of pRb in cells entering early G1 proteins were isolated from these cells by low-salt extraction followed by co-immunoprecipitation with anti-Rb and immunoblotting for Rb and E2F1 ( Figure 5 ). Raised intracellular We wished to explain the increased binding interaction between E2F1 and pRb that occurred in nuclei by raising cAMP increased the nuclear content of protein-protein complexes between E2F1 with the retinoblastoma protein, pRb, cellular cAMP content in early G1 phase because this was strongly associated with diminished activity of the P2 c-myc contained within cells traversing early G1 in culture ( Figure 5) .
In another series of functional reporter experiments, the promoter in functional assays. It was postulated that Rb phosphorylation by cdk4 was blocked by raised intracellular level of luciferase activity was compared in cells transfected with the minimal P2 promoter (wild-type E2F site)-containing cAMP. Therefore, the functional activity of cdk4 from cells in the different cell cycle fractions, treated or not with 8BrcAMP, vector and subjected to forskolin treatment vs the same cells subjected to control treatment after transfection with the miniwas tested ( Figure 6 ). Cdk4 was immunoprecipitated from the extracts of Bcrmal P2 c-myc promoter with E2F site mutated (data not shown). Both of these experimental groups were compared for Abl.A54 cells, either in the pooled population enriched for G1 phase by elutriation, and further incubated or not with reporter activity to cells transfected with the wild-type promoter and subjected to control treatment. In the S-to-G1 8BrcAMP, or in those cells exiting S for early G1 after elutriation, and incubated either in the presence of 8BcrAMP or population, the functional consequences of cAMP treatment on cells transfected with the wild-type P2 reporter was for not. Immune complex kinase assays were performed with GST-Rb as the substrate ( Figure 6 ). As might be predicted from equivalent inhibition of reporter activity as compared to E2F site mutation. As noted previously, however, forskolin did not our results in the 5Ј c-myc reporter assays dependent on E2F, cdk4 activity for phosphorylating pRb was greatest in extracts result in marked suppression of P2 wild-type reporter activity in the G1-S population (data not shown, see Figure 4) . from cells progressing from S through G1. Rb kinase activity Early G1 phase checkpoint for c-myc control involves critical regulation of cyclin D1
Possible explanations were considered for a regulatory influence of cAMP over cdk4 activity and c-myc transcription in early G1. We first addressed cellular content of cyclin D1, the regulatory subunit of the cdk4 holoenzyme. (Preliminary experiments revealed that cyclin D1 was the most abundant cyclin D species in these cells.) The content of cyclin D1 mRNA was assessed in the elutriated cell populations subjected to 6 h incubation in the presence or absence of 8BrcAMP ( Figure 3 ). Cyclin D1 transcripts were markedly inhibited by cAMP only in cells of fraction Ͼ26, subjected to incubation in the presence of 8BrcAMP (Figure 3 ). In this cell group transiting early G1 phase during cell culture incubation, cyclin D1 transcripts were found to be diminished by 86% upon treatment with 8BrcAMP ( Figure 3 ). On the other hand, 8BrcAMP did not significantly inhibit expression of cyclin D1 in the G1 (8-16) or G1/S (17-26) populations subjected to incubation for 6 h (Ͻ20% inhibition by densitometry) (Figure 3 ). Cell lysates were prepared to confirm the selective inhibitory effect of 8BrcAMP on cyclin D1 protein expression in cells transiting S-to-G1 (Figure 8 ). Immunoblotting corroborated, by protein levels, the effect of 8BrcAMP also noted on cyclin D1 transcripts; ie 8BrcAMP treatment reduced the amount of cyclin D1 protein in cells transiting the early G1 phase, but 8BrcAMP did not reduce cellular content of cyclin D1 protein in cells entering S phase in culture from G1-enriched cells (Figure 8 ). This result was entirely consistent with the cell cycle inhibitory effects of 8BrcAMP on cdk4 activity (see Figure 6) .
Finally, a test of the ability of 8BrcAMP to reduce cdk4-associated cyclin D in nuclear proteins was undertaken. This was done in order to confirm the role of diminished regulatory subunit assayed in cdk4 activity experiments noted above (see Discussion was three-fold greater in these nuclear extracts of cells progressing from S-to-G1, than was cdk4 activity for Rb in the The functional importance of c-myc transcriptional expression in the process of hematopoietic cell transformation by p210 nuclear extracts of cells leaving G1 (Figure 6 ). In addition, there was significant inhibition of cdk4 activity after cAMP BCR-ABL has been investigated. 4 We have described the requirement for a cis-acting DNA element for c-myc transcriptreatment in the extract of cells entering early G1 in culture after the elutriation procedure. On the other hand, cdk4 tion initiation in these cells. 11 This was the 5Ј c-myc P2 promoter motif TTGGCGGGGAAA that binds the transcription activity was not diminished by cAMP treatment within the extracts of cells leaving G1 in culture ( Figure 6 ). Control factor E2F. The current study was undertaken to determine if c-myc experiments revealed that cdk4 content in cells did not vary with the cell cycle, and its content was not inhibited by raised transcription in p210 BCR-ABL transformed cells, mediated through the transcriptional regulator E2F, is subject to control intracellular cAMP concentration (data not shown). The time of onset for cdk4 inhibition by 8BrcAMP treatment of the Sby raised intracellular cAMP. We have previously determined cAMP to be a critical second messenger inhibiting hematophase enriched (Ͼ26) elutriated cells was studied at intervals during incubation in culture. The 8BrcAMP-mediated inhipoietic transformation by p21ras pathway oncogene(s), 12, 13 and therefore we investigated the potential role cAMP may bition of cdk4 activity was greatest at 4-6 h (Figure 7) . Phosphorylation of Rb-GST by cdk4 was essentially abrogated at have in this putative p21ras-dependent proliferation endpoint downstream from p210 BCR-ABL, c-myc. these times.
Figure 5
Immunoprecipitation of nuclear proteins prepared from S-phase enriched elutriated cells synchronously entering G1 phase in culture, and treated or not with 8BrcAMP, reveals cAMP-mediated complex formation between pRb and E2F1.
Because the E2F transcription factor is known to be regu-GST-Rb from cell extracts (Figures 6 and 7) . Our expectation was that cdk4 activity might be relatively phase-specific for lated by pRb, the retinoblastoma protein, we sought to determine if cAMP might exert its proliferation-inhibitory program early G1, which we found to be true ( Figure 6 ). Partial phasedependence of cdk4 activity in CSF-1 treated macrophages through a cell cycle block imposed by pRb. We also investigated whether the G1 phase growth arrest may be associated has been observed by others. 20 Matsushime and colleagues 20 observed a 2-3-fold greater cdk4 kinase activity for pRb in with pRb-imposed transcriptional suppression of c-myc via the P2 promoter E2F element. These experiments were pursued mid-G1 vs S phase. It appeared likely that interruption of cdk4 activity by cAMP in the context of synchronous populations of p210 BCR-ABL transformed A54 cells, with the intent to define a hierarchy might occur at a point coincident with the peak of cdk4 activity in control cells. In fact, we found cdk4 activity for the between product (c-myc mRNA) expression and the antecedent regulatory influences on E2F, involving interactions substrate GST-Rb to be phasic, with highest enzymatic activity in cells in the early G1 phase (Figures 6 and 7) . This was the between G1 cyclins, pRb, and cdk4, the relevant cyclindependent kinase for pRb.
same cell cycle context for optimal E2F-dependent 5Ј c-myc reporter activity (Figures 4 and 6 ). Both of these endpoints: The central finding of this study was a strong inhibitory activity of raised intracellular cAMP on transcriptional pRb phosphorylation by cdk4, and 5Ј P2 c-myc luciferase production, were maximally inhibited from their highest activity expression of c-myc in p210 BCR-ABL transformed A54 cells synchronously transiting the early aspect of G1 phase. This by cAMP in cells progressing from S into G1 (Figures 4, 6 and  7) . On the other hand, nuclear cdk4 activity was significantly inhibitory program was causally associated with nuclear tethering of pRb in a form binding to E2F1, and loss of relative less, and P2 c-myc reporter activity approximately 2/3 lower, in cells synchronously exiting G1 for S phase, compared with abundance of 'free' protein-nonassociated E2F complexes with the E2F sites of P2 c-myc and E2A probes in gel mobility those cells entering G1 (Figures 4 and 6 ). Cyclin D has been noted to be actively excluded from the nucleus in cells shift experiments (Figures 4, 5 , and data not shown).
The route to cAMP-enforced regulation of Rb-E2F1 was entering S phase, perhaps as a function of loss of tethering to pRb. [25] [26] [27] This may account for the comparative diminution of investigated by direct measurement of cdk4 kinase activity for Cdk4 activity is phasic in the cell cycle, with greatest activity within cells entering G1 phase after incubation of cells purified for S phase DNA content by elutriation. Inhibition of cdk4 activity by cAMP is greatest in this group entering early G1. Equal quantities of protein from the two elutriated fractions were immunoprecipitated with anti-cdk4 and the immune precipitate incubated with GST-Rb and 32P-ATP as described in the text. Control groups subjected to mock immunoprecipitation had no cdk4 activity (not shown).
Figure 7
Time course for 8BrcAMP-induced inhibition of cdk4 kinase activity on GST-Rb. Extracts were prepared from S-phase enriched cells (obtained by centrifugal elutriation) subjected to incubation in culture in the absence or presence of 8BrcAMP (1 mm) for 1, 2, 4, 6, 10 h, or overnight. Equal quantities of extracts were immunoprecipitated with anti-cdk4, then subjected to immune complex kinase assay with GSTRb, and 32 P-ATP. Contents of the reaction were subjected to SDS-PAGE and autoradiography as described. Another aliquot of these same cell extracts was subjected to SDS-PAGE, and immunoblotting to demonstrate cdk4 content was not affected by cAMP. The apparent decrease of cdk4 abundance in the 4 h 8BrcAMP lane was noted to result from underloading as demonstrated by reprobing the immunoblot with anti-actin. Note that cdk4 levels are entirely equal at all other time-points. Repeats of this experiment confirmed the validity of this conclusion.
cdk4 enzymatic activity we observed of cells entering the S vation arose from further studies of the equilibrium concentrations of cdk4 and its regulatory partner cyclin D (D1), phase (see Figure 8) . [25] [26] [27] Importantly, cAMP inhibition of cdk4 activity was less prowhose synthesis was not inhibited by cAMP in the cells exiting G1 (Figure 3) . Therefore, expression of the major early G1 found, or absent, in the synchronous cell population en route from G1 to S. An apparent explanation for this latter obsercyclin, cyclin D1, was inhibited in its formation by raised
Figure 8
Inhibition of cyclin D1 protein expression revealed by immunoblotting of whole cell or nuclear extracts prepared from elutriated cells incubated in culture with 8BrcAMP. Filters containing whole cell or nuclear extracts were first immunoblotted with anti-cyclin D1, then reprobed with an actin antibody. Note relative exclusion of cyclin D1 protein from nuclei of cells transiting G1-to-S (right). 8BrcAMP decreased the amount of cyclin D1 protein by 78% in whole cell extracts, or by 67% in nuclear extracts, prepared from cells transiting G1, as demonstrated by densitometry.
intracellular cAMP (at both mRNA and protein levels) in the ment after an apparent restriction point had been passed in the bulk cells isolated by elutriation for G1 DNA content and cell fraction synchronously progressing into, rather than away from, G1 phase ( Figures 3, 8 and 9) . Recently, suppression of subjected to further incubation. Therefore, we concluded that the major route to cAMP's E2F-dependent repression of c-myc transcriptional expression of cyclin D1 was linked to intracellular cAMP content and cAMP regulatory repressor transcription initiation in p210 BCR-ABL transformed cells involved a specific inhibition of cyclin D1 expression in cells elements were identified in the 5Ј regulatory region of the cyclin D1 gene. 28, 29 Also, raised intracellular cAMP has been transiting, rather than exiting, G1 phase. However, Hatakeyama et al 34 have recently suggested that noted to inhibit signaling downstream of p21 ras, at the level of MAP/ERK kinase, which appears to be in a signaling pathcyclin D interaction with cdk4 accounts for only part of the regulatory phosphorylation of Rb, and they have even sugway from p21ras to cyclin D1 transcriptional expression. [30] [31] [32] Therefore, we hypothesize that cyclin D levels, which have gested that direct binding of cyclin D to the Rb 'pocket' region may be its major Rb-inhibitory activity. In this model, ligandbeen found to be relatively invariant throughout most phases of the cell cycle past the point of G0 exit, 33 are critically sensidependent phosphorylation of pRb may also be attributed to cyclin E. On the other hand, in our studies cyclin E was tive to intracellular cAMP levels at the G0/G1 transition. This may be a critical decision point for restricting expression of inhibited by raised cAMP in both elutriated fractions (G1-to-S, and S-to-G1) but only in the S-to-G1 fraction incubated certain E2F-dependent G1 genes, such as c-myc, which are sensitive to the intracellular levels of cyclin D, and, hence, to with cAMP was strongest inhibition of the formation of 'free' E2F and marked inhibition of c-myc expression observed cAMP. We were able to target an early G1 restriction point with cAMP in a synchronized population purified for S-phase ( Figure 4 , and data not shown). In addition, our studies found a close correspondence between functional suppression of P2 cells, and then subjected to further incubation. Because we found no effect of cAMP on levels of cdk4 in any of the synchc-myc-mediated reporter activity by cAMP in cells entering G1 phase with blunted cyclin D1 expression, which appeared ronized populations, particularly the S-to-G1 population ( Figure 7 , and data not shown), we infer that deficiency of to involve E2F-dependent regulatory interactions. Interestingly, Birchenall-Roberts and colleagues 35 recently studied the cyclin D within the cyclin-dependent kinase holoenzyme contributes to diminished Rb kinase activity induced by cAMP in inhibitory mechanism of TGF␤ in IL-3-dependent 32D myeloid cells and found no evidence of an inhibitory effect A54 cells entering early G1.
The failure of cAMP to mediate suppression of cdk4 kinase by TGF␤ on cyclin D, or any effect on pRb activity. Rather, the authors suggested that cyclin E, p107, and cdk2 were activity within cells leaving G1 for S phase may be explained by the fact that cyclin D content was resistant to cAMP treataffected by TGF␤, supporting a chronologically later cell cycle activity than we observed for cAMP in myeloid cells.
Figure 9
Immunoblotting reveals that raised intracellular cAMP blocks formation of cyclin D, but not cdk4, protein in cells synchronously entering G1 phase. Immunoprecipitation of nuclear protein from A54 cells treated or not with 8BrcAMP, with antibody to cdk4, and then immunoblotting for either cdk4 or cyclin D, demonstrates the content of cyclin D in complex with cdk4 is reduced by cAMP in cells synchronously entering G1.
The simplest explanation for the inactivation of E2F by dependent nontransformed myeloid cells, found cdk4 to be an IL-3-dependent early response gene, whose accumulation raised intracellular cAMP that we observed involves upstream equilibrium interactions among only cyclin D, cdk4, and pRb.
was inhibited by transforming growth factor ␤. Another possible aspect of cAMP signaling capable of inhibiting cdk4 However, other mechanistic possibilities exist. One possibility is the failure, imposed by cAMP, of cdk4 phosphorylation on activity for pRb in our cells, thus leading to c-myc transcriptional repression, involves potential cAMP effects on the levels threonine residue 172, required for cdk4 activation. 36 This is normally accomplished by a ubiquitous multicomponent or activity of p16 INK4 (inhibitor of cdk4).
33,44
We did observe a much more modest degree of cAMPcdk4-activating kinase (CAK) made up of a cdk-like catalytic subunit called MO15/cdk7, and its regulatory partner cyclin induced c-myc transcriptional repression of cells having G1 DNA content and subjected to further incubation in the pres-H. 36, 37 Inhibition of CAK activity can be accomplished by stoichometric increases in the concentration of a p27 kinase ence of 8BrcAMP, which was not accounted for by inhibition of cdk4 activity. We speculate that this repression may relate inhibitory protein (kip) or of p16 MTS1, which are capable of acting in mid-G1 to sterically block CAK access to cdk4. 38 In to cAMP activation of nuclear protein phosphatase-1. Nuclear protein phosphatase-1 (PP-1) is felt to normally dephosphoryfact, Kato and colleagues 39 have recently reported that increased cAMP can mediate G1-phase arrest in macrophages late pRb upon exit from cellular mitosis, and to be inhibited as cells enter G1, allowing cdk4 to act. [45] [46] [47] [48] cAMP-dependent stimulated by the growth factor, colony-stimulating factor-1 (CSF-1), by this mechanism. However, in their study, cyclin protein kinase (protein kinase A) directly activates nuclear PP-1, and it is possible that this activation may explain the more D levels in cells were not affected by cAMP, whereas others have observed inhibition of cyclin D by cAMP. 28, 33, 39, 40 In the modest inhibition of c-myc transcription in cells exiting G1, where cdk4 is no longer a a relevant restrictive influence. IL-3-dependent cells that gave rise to Bcr-Abl.A54, called NFS/N1.H7, we also found that cdk4 activity was dependent Diminished accumulation of additional phosphate groups on ppRb by loss of cyclin E activation of cdk2 may also be upon IL-3-mediated increase in cyclin D1, and that cdk4 activity, but not cyclin D1 content, was inhibited by increased involved here.
The current studies provide a focus for future studies of the intracellular cAMP (data not shown). Therefore, it is possible that sensitivity for inhibition of cyclin D1 accumulation by route from p210 BCR-ABL to the cdk4 regulatory subunit, cyclin D1. Recently, investigators have found cyclin D1 overcAMP is a specific property of the proliferative signal delivered by p210 BCR-ABL, but not of the IL-3 signal in expression to result from mutant p21ras transformation of fibroblasts.
31,32
We conclude that c-myc transcription myeloid cells.
In other studies implicating G1 cell cycle arrest by inhibiinitiation in p210 BCR-ABL transformed cells is controlled, in part, at the level of cdk4 activation involving regulation of tory cytokines/mediators, the level of cdk4 has been found limiting. [41] [42] [43] A study by Ando and Griffin 43 on growth factorcyclin D1 expression, and therefore may incorporate a
